Insulin by itself doesn’t change estrogen production in fat, but when it’s with cortisol, it makes the difference between men and women disappear.
Scientific Claim
Insulin alone has no effect on aromatase activity in human adipose tissue, but when combined with cortisol, it eliminates sex- and site-specific differences in aromatase activity, suggesting insulin modulates glucocorticoid effects.
Original Statement
“Insulin had no independent effect on aromatase expression, but coincubation of preadipocytes with cortisol and insulin eliminated both gender- and site-specific differences.”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study is ex vivo and lacks in vivo validation; the term 'eliminated' implies complete abolition, which cannot be confirmed without systemic context. Only association is supported.
More Accurate Statement
“Insulin alone is not associated with changes in aromatase activity, but when combined with cortisol, it is associated with the loss of sex- and site-specific differences in aromatase activity, suggesting an interaction between these hormones.”
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1bWhether acute insulin infusion alters cortisol-induced aromatase activity differently in men and women in vivo.
Whether acute insulin infusion alters cortisol-induced aromatase activity differently in men and women in vivo.
What This Would Prove
Whether acute insulin infusion alters cortisol-induced aromatase activity differently in men and women in vivo.
Ideal Study Design
A double-blind, crossover RCT of 40 healthy adults (20 men, 20 women) receiving intravenous cortisol (10⁻⁶ M equivalent) with or without insulin infusion (0.1 mU/kg/min) for 4 hours, measuring subcutaneous and omental aromatase activity via microdialysis and fat biopsy.
Limitation: Cannot assess long-term effects or fat distribution outcomes.
Prospective Cohort StudyLevel 2bWhether individuals with higher insulin levels show reduced sex differences in aromatase activity in adipose tissue.
Whether individuals with higher insulin levels show reduced sex differences in aromatase activity in adipose tissue.
What This Would Prove
Whether individuals with higher insulin levels show reduced sex differences in aromatase activity in adipose tissue.
Ideal Study Design
A 2-year cohort of 500 adults (250 men, 250 women) with fasting insulin and cortisol measurements and paired fat biopsies, analyzing aromatase activity and its correlation with insulin sensitivity.
Limitation: Cannot prove insulin directly modulates cortisol’s effect; confounding by obesity or diet possible.
In Vitro Cell Culture StudyLevel 4In EvidenceWhether insulin co-treatment abolishes cortisol-induced sex differences in aromatase activity in human adipose cells.
Whether insulin co-treatment abolishes cortisol-induced sex differences in aromatase activity in human adipose cells.
What This Would Prove
Whether insulin co-treatment abolishes cortisol-induced sex differences in aromatase activity in human adipose cells.
Ideal Study Design
A replicated in vitro study using preadipocytes from 50 donors (25 men, 25 women), treated with cortisol (10⁻⁶ M), insulin (500 nM), both, or neither, measuring aromatase activity and signaling pathways.
Limitation: Does not reflect systemic hormonal dynamics or tissue crosstalk.
Evidence from Studies
Supporting (1)
Glucocorticoid regulation of p450 aromatase activity in human adipose tissue: gender and site differences.
Insulin by itself doesn’t change estrogen production in fat cells, but when it’s given with cortisol (a stress hormone), it makes the difference between men and women disappear — meaning insulin changes how cortisol works.